Back to today’s briefing

Story perspectives

Vertex CSO David Altshuler Steps Down After 10 Years

8/6/2025

33 2

Summary

Story summary

David Altshuler, the visionary Chief Scientific Officer of Vertex Pharmaceuticals, will step down on August 1, 2026, after nearly ten transformative years. Under his leadership, Vertex broadened its research horizons beyond cystic fibrosis, launching groundbreaking therapies like the first CRISPR gene editing treatment. Mark Bunnage will take the reins, continuing this legacy of innovation.

1 of 1

Story summary

David Altshuler, the visionary Chief Scientific Officer of Vertex Pharmaceuticals, will step down on August 1, 2026, after nearly ten transformative years. Under his leadership, Vertex broadened its research horizons beyond cystic fibrosis, launching groundbreaking therapies like the first CRISPR gene editing treatment. Mark Bunnage will take the reins, continuing this legacy of innovation.